Ryman Healthcare (NZX:RYM)
ASX announcement history & article coverage
Transparent by design.
Announcments by Ryman Healthcare (NZX:RYM) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
SPH Notice - FirstCape Group Limited
SPH Notice - Harbour Asset Management Limited
Ryman Healthcare Limited - Proxy Form 2026
Ryman Healthcare Limited - Notice of Meeting 2026
Ryman Healthcare Limited - ASX Listing Rule 1.15.3
RYM – Trading to resume at market open
Capital Change Notice - RYM010 Bonds
RYM010 Trading Halt Application
Ryman Healthcare Limited ("RYM010") - Trading Halt of Securities
Ryman Healthcare Limited - 2026 Governance Presentation
Quotation Notice - Ryman Healthcare Limited Bonds ("RYM020")
Ryman Healthcare Limited - Final Terms Sheet
Ryman Healthcare Limited - Ryman releases final terms sheet
Ryman Healthcare Limited - Cleansing notice
Ryman Healthcare Limited - Ryman sets interest rate for retail bond offer
Ryman Healthcare Limited - Ryman closes its retail bond offer
Ryman Healthcare Limited (“RYM”) exchange mechanism of RYM010 bonds for RYM020 bonds
Ryman Healthcare Limited - Retail bond presentation
Ryman Healthcare launches NZ$100 million 6-year secured bond offer to refinance debt and diversify funding
Ryman Healthcare Limited - Ryman launches fixed rate retail bond offer
Ryman Healthcare launches NZ$100 million fixed rate bond offer maturing 2032
Ryman Healthcare Limited - Indicative terms sheet
Ryman Healthcare launches up to NZ$100 million fixed rate bonds maturing 2032 with exchange option for existing bonds
Ryman Healthcare Limited - Cleansing notice
Ryman Healthcare issues cleansing notice for new fixed rate secured bonds
Ongoing Disclosure Notice – Hamish Rumbold
Ryman Healthcare Limited - Corporate Governance Statement
Ryman Healthcare FY26 Corporate Governance Statement Highlights Strong Governance and Transparency
Ryman Healthcare Limited - FY26 Annual Report
Ryman Healthcare reports improved FY26 performance, strategic shift to sustainable growth, and plans dividend return by FY28
Closing date for director nominations
Ongoing Disclosure Notice – James Miller
Ongoing Disclosure Notice – Naomi James
Ongoing Disclosure Notice – Matthew Prior
Ryman considers retail bond offer
Ongoing Disclosure Notice - Dean Hamilton 02-06-2026
Ongoing Disclosure Notice - David Pitman 02-06-2026
Ryman Healthcare Limited - Financial Statements - 31 March 2026
Ryman Healthcare reports NZD 171 million loss, completes refinancing and land divestments
Ryman Healthcare Limited - Results Presentation - 31 March 2026
Ryman Healthcare FY26: Operating EBITDAF up 94%, positive free cash flow, strategy refreshed, FY27 guidance set
Ryman Healthcare Limited - NZX & ASX Release - 31 March 2026
Ryman Healthcare posts strong FY26 results, first positive free cash flow in a decade, and sets clear FY29 targets
Ryman Healthcare Limited - Announcement Numbers - 31 March 2026
Ryman Healthcare posts revenue growth but reports significant net loss and suspends dividend for FY2026
Ryman Healthcare Limited - NZX ASX Release 24 April 2026
Ryman Healthcare Limited - NZX & ASX Release_1 15-04-2026
Ryman Healthcare Q4 FY26 sales up 10% year-on-year, FY26 sales meet guidance with strong cash flow forecast
Ryman Healthcare Limited - NZX & ASX Release_2 15-04-2026